129 related articles for article (PubMed ID: 4917976)
1. Factors pertaining to complete drug-induced remission of tumor in animals and man.
Goldin A
Cancer Res; 1969 Dec; 29(12):2285-91. PubMed ID: 4917976
[No Abstract] [Full Text] [Related]
2. Combination chemotherapy in sequence for the treatment of L1210 leukemia.
Roberts D; Hilliard SL
Cancer Res; 1978 Aug; 38(8):2317-20. PubMed ID: 667827
[No Abstract] [Full Text] [Related]
3. Sequential administration of two oncostatic drugs: study of modalities for pharmacodynamic potentiation.
Pouillart R; Huong TH; Brugerie E; Lheritier J
Biomedicine; 1974 Dec; 21(12):471-9. PubMed ID: 4462870
[No Abstract] [Full Text] [Related]
4. Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone.
Burns ER; Scheving LE
Chronobiologia; 1980; 7(1):41-51. PubMed ID: 7438892
[No Abstract] [Full Text] [Related]
5. Rationale of chemotherapeutic adjuvant treatment.
Goldin A
Arch Geschwulstforsch; 1978; 48(7):627-35. PubMed ID: 736743
[No Abstract] [Full Text] [Related]
6. Criteria associated with destruction of leukemia and solid tumor cells in animals.
Skipper HE
Cancer Res; 1967 Dec; 27(12):2636-45. PubMed ID: 6082300
[No Abstract] [Full Text] [Related]
7. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.
Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
Cancer Chemother Rep 2; 1972 Nov; 3(1):1-69. PubMed ID: 4660732
[No Abstract] [Full Text] [Related]
8. [L 1210 leukemia, an experimental model for the potentiation of drugs used for acute leukemias].
Pouillart P; Huong TH; Lhéritier J
Bull Cancer; 1974; 61(4):509-26. PubMed ID: 4458834
[No Abstract] [Full Text] [Related]
9. An assessment of massive-dose chemotherapy of malignant disease.
Bergsagel DE
Can Med Assoc J; 1971 Jan; 104(1):31-6. PubMed ID: 4322068
[No Abstract] [Full Text] [Related]
10. Duration of drug levels in mice as indicated by residual antileukemic efficacy.
Kline I; Gang M; Tyrer DD; Mantel N; Venditti JM; Goldin A
Chemotherapia (Basel); 1968; 13(1):28-41. PubMed ID: 5656314
[No Abstract] [Full Text] [Related]
11. Single versus combination chemotherapy of L1210 leukemia.
Koza I; Balázová E; Ujházy V
Neoplasma; 1980; 27(6):691-6. PubMed ID: 7254424
[TBL] [Abstract][Full Text] [Related]
12. Effect of different doses of methotrexate (NSC-740), cytosine arabinoside (NSC-63878), and cyclophosphamide (NSC-26271) on drug resistance in mice with L1210 leukemia.
Schmid FA; Hutchison DJ
Cancer Chemother Rep; 1972 Aug; 56(4):473-81. PubMed ID: 5081590
[No Abstract] [Full Text] [Related]
13. [The effect of various doses of nitrosomethyl (ethyl) urea on the development of spontaneous leukosis and tumors in mice].
Marytnova RP; Ronichevskaia GM; Sekirov BA
Vopr Onkol; 1969; 15(6):53-6. PubMed ID: 5811124
[No Abstract] [Full Text] [Related]
14. Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules.
Skipper HE; Schabel FM; Mellett LB; Montgomery JA; Wilkoff LJ; Lloyd HH; Brockman RW
Cancer Chemother Rep; 1970 Dec; 54(6):431-50. PubMed ID: 5527023
[No Abstract] [Full Text] [Related]
15. Combined chronochemotherapy of L1210 leukemic mice using 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine, methylprednisolone and cis-diamminedichloroplatinum.
Scheving LE; Burns ER; Halberg F; Pauly JE
Chronobiologia; 1980; 7(1):33-40. PubMed ID: 7192203
[TBL] [Abstract][Full Text] [Related]
16. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on leukemia L1210.
Mihich E; Mulhern AI
Cancer Res; 1968 Feb; 28(2):354-62. PubMed ID: 5641525
[No Abstract] [Full Text] [Related]
17. Chemotherapy of leukemia L1210 in mice with 1-beta-d-arabinofuranosylcytosine hydrochloride. I. Influence of treatment schedules.
Kline I; Venditti JM; Tyrer DD; Goldin A
Cancer Res; 1966 May; 26(5):853-9. PubMed ID: 5936445
[No Abstract] [Full Text] [Related]
18. Collateral sensitivity of resistant lines of mouse leukemias L1210 and L5178Y.
Schmid FA; Hutchison DJ
Cancer Res; 1972 Apr; 32(4):808-12. PubMed ID: 5014791
[No Abstract] [Full Text] [Related]
19. Clinical studies with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037).
Hansen HH; Selawry OS; Muggia FM; Walker MD
Cancer Res; 1971 Mar; 31(3):223-7. PubMed ID: 4926242
[No Abstract] [Full Text] [Related]
20. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX.
Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
Cancer Chemother Rep 2; 1971 Apr; 2(1):65-133. PubMed ID: 5565539
[No Abstract] [Full Text] [Related]
[Next] [New Search]
